Barry Mathis, Principal, PYA, speaks with Katherine Snow, Privacy Counsel, Hinge Health Inc., and Alya Sulaiman, Partner, McDermott Will & Emery LLP, about how artificial intelligence (AI) continues to transform health care and the various legal and compliance considerations. They discuss how health care organizations should manage governance of AI; the legislative and regulatory environment; and concerns related to intellectual property, privacy, and bias.

+Listen to Episode 1

Kathy Reep, Senior Manager, PYA, speaks with Kevin Malone, Member of the Firm, Epstein Becker & Green PC, about trends and developments related to mental health parity and the Mental Health Parity and Addiction Equity Act (MHPAEA). They discuss the July 2023 proposed rule related to the MHPAEA and its implications, issues related to non-quantitative treatment limitations, and the nature of comments being submitted on the proposed rule. From AHLA's Behavioral Health Practice Group.

+Listen to Episode 2

Michael Ramey, Managing Principal, PYA, speaks with Rosa M. Morales, Counsel, Crowell & Moring LLP, about the major antitrust trends affecting the health care industry. They discuss the DOJ and FTC’s 2023 merger guideline changes, how the health care industry is impacted by the agencies’ focus on pursuing “less traditional theories of harm” and closer scrutiny of labor market impacts, and recommendations for counsel to manage the proposed new Hart-Scott-Rodino requirements.

+Listen to Episode 3

Lori Foley, Office Managing Principal, PYA, speaks with Jonathan A. Porter, Partner, Husch Blackwell LLP, about the major fraud and abuse issues in the health care space. They discuss the importance of the SuperValu case on the health care industry, the impact of split circuits, and key compliance takeaways for providers. From AHLA's Fraud and Abuse Practice Group.

+Listen to Episode 4

Deborah Biggs, Principal, PYA, speaks with Tiffany Buckley-Norwood, Associate Counsel, Trinity Health Corporation, about the impact of the Supreme Court’s decision in Students for Fair Admissions v. Harvard/UNC on diversity programs across the country. They discuss the impacts at the federal and state levels, how diversity programs can navigate this new environment, and best practices for creating a pipeline of diversity in health care. From AHLA’s Labor and Employment Practice Group.

+Listen to Episode 5

Carol Carden, Managing Principal, PYA, speaks with Joanne (Jody) Joiner, Senior Counsel, Tenet Healthcare, and Gina L. Bertolini, Partner, K&L Gates LLP, about the constantly changing reproductive health space. They discuss recent federal developments, the interplay between EMTALA and state laws, abortion access at the state level, the impact of the Cox case in Texas, litigation related to interstate travel, and issues related to privacy.

+Listen to Episode 6

Debbie Ernsberger, Principal, PYA, speaks with Douglas M. Mancino, Partner, Seyfarth Shaw LLP, about the tax-related issues that the health care industry faces. They discuss what tax-exempt organizations should anticipate related to community benefit, Section 501(r) compliance, best practices regarding community benefit data, and executive compensation. Sponsored by PYA.

+Listen to Episode 7

Martie Ross, Consulting Principal, PYA, speaks with Caroline Brown, Partner, Brown & Peisch PLLC, about current proposals that are on the table for Medicaid that may come to fruition in 2024. They discuss how the regulatory process works between CMS and the states and the proposed rules related to quality rating systems, payment adequacy and access, medical loss ratio, network adequacy requirements, and prior authorization.

+Listen to Episode 8

Karin Anderson, Principal & Corporate Counsel, PYA, speaks with Carolyn V. Metnick, Partner, Sheppard Mullin Richter & Hampton LLP, about the impact of tracking technology on health care and the accompanying legal and regulatory issues. They discuss what tracking technology is, what OCR is requiring of HIPAA-covered entities, recommendations for health care providers to ensure they are complying with OCR, and current enforcement and litigation activities.

+Listen to Episode 9

Sarah Bowman, Principal, PYA, speaks with Jolee H. Bollinger, Deputy General Counsel, Sharp HealthCare, and Andrew D. Ruskin, Partner, K&L Gates LLP, about potential 340B activity in 2024 as drug manufacturers continue to tighten access to 340B pricing. They discuss the impact of the Genesis case, how covered entities can navigate this uncertain environment and protect their access to 340B pricing, and trends pertaining to audits of covered entities.

+Listen to Episode 10